A gene expression signature of MEK pathway activation to predict survival in triple-negative breast cancer.

被引：0
|
作者：
Balko, Justin M.
Sanders, Melinda
Gabriela Kuba, Maria
Pinto, Joseph A.
Doimi, Franco F.
Leonidas Gomez, Henry
Arteaga, Carlos L.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Oncosalud, Div Invest, Lima, Peru
[4] Inst Nacl Enfermedades Neoplas, Lima, Peru
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1024
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gene expression in triple-negative breast cancer in relation to survival
    Wang, Shuyang
    Beeghly-Fadiel, Alicia
    Cai, Qiuyin
    Cai, Hui
    Guo, Xingyi
    Shi, Liang
    Wu, Jie
    Ye, Fei
    Qiu, Qingchao
    Zheng, Ying
    Zheng, Wei
    Bao, Ping-Ping
    Shu, Xiao-ou
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 199 - 207
  • [2] Gene expression in triple-negative breast cancer in relation to survival
    Shuyang Wang
    Alicia Beeghly-Fadiel
    Qiuyin Cai
    Hui Cai
    Xingyi Guo
    Liang Shi
    Jie Wu
    Fei Ye
    Qingchao Qiu
    Ying Zheng
    Wei Zheng
    Ping-Ping Bao
    Xiao-ou Shu
    [J]. Breast Cancer Research and Treatment, 2018, 171 : 199 - 207
  • [3] An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
    Bo Zhang
    Rong Zhao
    Qi Wang
    Ya-Jing Zhang
    Liu Yang
    Zhou-Jun Yuan
    Jun Yang
    Qian-Jun Wang
    Liang Yao
    [J]. Advances in Therapy, 2023, 40 : 4339 - 4357
  • [4] MHC II antigen presentation pathway expression in triple-negative breast cancer.
    Forero-Torres, Andres
    Varley, Katherine E.
    Li, Yufeng
    Chen, Dongquan
    Grizzle, William E.
    Downs-Kelly, Erinn
    Burwell, Todd C.
    Buchsbaum, Donald J.
    Myers, Richard M.
    LoBuglio, Albert F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
    Zhang, Bo
    Zhao, Rong
    Wang, Qi
    Zhang, Ya-Jing
    Yang, Liu
    Yuan, Zhou-Jun
    Yang, Jun
    Wang, Qian-Jun
    Yao, Liang
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4339 - 4357
  • [6] BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.
    Rodriguez, A. A.
    Makris, A.
    Harrison, M. K.
    Ostler, P. J.
    Froehlich, A.
    Pavlick, A.
    Wong, H.
    Tsimelzon, A.
    Sexton, K.
    Hilsenbeck, S. G.
    Lewis, M. T.
    Rimawi, M.
    Osborne, C. K.
    Chang, J. C.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 358S - 358S
  • [7] Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.
    Iwase, Toshiaki
    Pusztai, Lajos
    Blenman, Kim
    Li, Xiaotong
    Seitz, Robert
    Nielsen, Tyler J.
    Schweitzer, Brock L.
    Hout, David Richard
    Bailey, Dan B.
    Zhang, Xiang
    Shen, Yichao
    Ueno, Naoto T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Three-microRNA expression signature predicts survival in triple-negative breast cancer
    Wu, Xinquan
    Ding, Mingji
    Lin, Jianqin
    [J]. ONCOLOGY LETTERS, 2020, 19 (01) : 301 - 308
  • [9] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [10] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345